See also this year's filing and all EDGAR filings for this company.
PDF Report 0001061027_2020_Viracta_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001061027, Viracta Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 36,322,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,000 |
| 3 | remainder_Assets | 915,000 |
| 4 | LiabilitiesCurrent | 9,416,000 |
| 5 | LiabilitiesNoncurrent | 281,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,949,000 |
| 9 | ResearchAndDevelopmentExpense | 15,412,000 |
| 10 | remainder_Expenses | 514,000 |
| 11 | remainder_Revenues | 2,073,000 |
| 12 | remainder_NetIncome | 472,000 |
| 13 | remainder_ComprehensiveNetIncome | 1,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 37,240,000 |
| 1 | Liabilities | 9,697,000 |
| 2 | Expenses | 25,875,000 |
| 3 | Revenues | 2,073,000 |
| 4 | StockholdersEquity | 27,543,000 |
| 5 | NetIncome | -23,330,000 |
| 6 | ComprehensiveNetIncome | -23,329,500 |
| 7 | BaseVar | 37,679,000 |
| 8 | EconomicCapitalRatio | 1.02 |
Edgar->Model Mapping
Feature Distribution
Change over Time
